New drug pricing policy raises concerns

Published: 2013-09-24 06:59:00

Updated: 2013-09-24 06:59:00

The government’s plan to implement its revised volume forecast plan for a drug starting next year has triggered concerns from the domestic pharmaceutical community.

Under the plan, drug manufacturers and the National Health Insurance Corp. will be called to discuss the volume forecasts for a ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK